Overview

Effect of Different Boosting Agents on Pharmacokinetics of BILR 355 BS Dissolved in Polyethylene Glycol 400 (PEG 400) in Healthy Male Volunteers

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Assessment of the effect of different boosting agents on pharmacokinetics of a single dose of BILR 355 BS dissolved in PEG 400
Phase:
Phase 1
Details
Lead Sponsor:
Boehringer Ingelheim
Treatments:
Atazanavir Sulfate
Nelfinavir
Ritonavir